|BIBCL -- India Stock|| |
INR 8.07 0.17 2.15%
The Macroaxis Fundamental Analysis lookup allows users to check a given indicator for any equity or select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners
to view more equity screening tools
Bharat Immunologicals Current Valuation Analysis
Enterprise Value is a firm valuation proxy that approximates current market value of a company. It is typically used to determine takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that company has on its balance sheet. When takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Bharat Immunologicals ValuationFundamentalsBuy or Sell
|Bharat Immunologicals ||Current Valuation|| = |
About Current Valuation
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.Compare to competition
In accordance with recently published financial statements Bharat Immunologicals Biologicals Corp Ltd has Current Valuation of 366.93M. This is 97.45% lower than that of the Healthcare sector, and 92.1% lower than that of Biotechnology
industry, The Current Valuation for all stocks is 97.79% higher than the company.
View history of all your transactions and understand their impact on performance
Bharat Immunologicals current financial ratios